Dr. Peter Hendricks, PhD
Claim this profileUniversity of Alabama at Birmingham
Studies Nicotine Addiction
Studies Cocaine Use Disorder
6 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Peter Hendricks, PhD is currently running
Extended-Release Naltrexone + Buprenorphine
for Cocaine Use Disorder
This trial tests a combination of two medications, naltrexone and buprenorphine, for adults addicted to cocaine. Naltrexone blocks the high from cocaine, while buprenorphine helps reduce cravings and withdrawal symptoms. The goal is to see if this combination is more effective. Buprenorphine has been proposed as a treatment for cocaine abuse, and its combination with naltrexone has shown potential in reducing cocaine intake.
Recruiting0 awards Phase 26 criteria
Psilocybin
for Demoralization
The purpose of the present study is to evaluate the feasibility, initial signals of efficacy, and potential mechanisms of action of "microdoses" of psilocybin (i.e., low doses of psilocybin that are not believed to produce mystical-type, transcendent, hallucinogenic, or other overtly salient subjective effects that limit functionality) in the treatment of moderate to severe demoralization (feelings of hopelessness and meaningless that frequently accompany medical illness and other life hardship).
Recruiting0 awards Phase < 16 criteria
More about Peter Hendricks, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Peter Hendricks, PhD has experience with
- Psilocybin
- Cognitive-behavioral Withdrawal Regulation Strategies
- Early Withdrawal Exposure
- Relaxation Strategies
- Niacin
- Extended Release Buprenorphine
Breakdown of trials Peter Hendricks, PhD has run
Nicotine Addiction
Cocaine Use Disorder
Smoking Addiction
Tobacco Use Disorder
Cocaine Dependence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Hendricks, PhD specialize in?
Peter Hendricks, PhD focuses on Nicotine Addiction and Cocaine Use Disorder. In particular, much of their work with Nicotine Addiction has involved treating patients, or patients who are undergoing treatment.
Is Peter Hendricks, PhD currently recruiting for clinical trials?
Yes, Peter Hendricks, PhD is currently recruiting for 5 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Peter Hendricks, PhD has studied deeply?
Yes, Peter Hendricks, PhD has studied treatments such as Psilocybin, Cognitive-behavioral Withdrawal Regulation Strategies, Early Withdrawal Exposure.
What is the best way to schedule an appointment with Peter Hendricks, PhD?
Apply for one of the trials that Peter Hendricks, PhD is conducting.
What is the office address of Peter Hendricks, PhD?
The office of Peter Hendricks, PhD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35294 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.